
Breaking News in Pharma Patents: What You Need to Know to Stay Ahead
Today, I’m going to break down some major developments in the pharma patent world and what they mean for your IP strategy. The FTC’s Crackdown on “Junk” Patents: What You Must Do The FTC is on a mission to clean up what they call “junk” drug patents listed in the FDA’s Orange Book. They’ve got …











